Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
ObjectiveTo explore the effectiveness of cryoablation combined with arterial perfusion with programmed cell death protein 1 inhibitors in overcoming immune resistance in advanced solid cancers.MethodsIn this pilot retrospective study, nine patients with solid cancers were treated with tumour cryoabl...
Main Authors: | Fuqun Wei, Rui Guo, Yuan Yan, Ruixiang Lin, Jin Chen, Zhengyu Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.990224/full |
Similar Items
-
Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer
by: Flávia Sardela de Miranda, et al.
Published: (2023-10-01) -
Argon-helium knife cryoablation plus programmed cell death protein 1 inhibitor in the treatment of advanced soft tissue sarcomas: there is no evidence of the synergistic effects of this combination therapy
by: Jiaqiang Wang, et al.
Published: (2023-09-01) -
Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour‐specific immunity
by: Zezhong Mou, et al.
Published: (2023-05-01) -
PD-1 monoclonal antibodies enhance the cryoablation-induced antitumor immune response: a breast cancer murine model research
by: Ze-Peng Yu, et al.
Published: (2023-12-01) -
Prostate cryoablation: A mini review
by: Zheng Xia, et al.
Published: (2023-12-01)